Literature DB >> 23036070

Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis.

Hiroshi Sogawa1, Brian Shrager, Ghalib Jibara, Parissa Tabrizian, Sasan Roayaie, Myron Schwartz.   

Abstract

OBJECTIVES: The relative roles of liver resection (LR) and liver transplantation (LT) in the treatment of a solitary hepatocellular carcinoma (HCC) remain unclear. This study was conducted to provide a retrospective intention-to-treat comparison of these two curative therapies.
METHODS: Records maintained at the study centre for all patients treated with LR or listed for LT for hepatitis C-associated HCC between January 2002 and December 2007 were reviewed. Inclusion criteria required: (i) an initial diagnosis of a solitary HCC lesion measuring ≤ 5 cm, and (ii) Child-Pugh class A or B cirrhosis. The primary endpoint analysed was intention-to-treat survival.
RESULTS: A total of 75 patients were listed for transplant (LT-listed group) and 56 were resected (LR group). Of the 75 LT-listed patients, 23 (30.7%) were never transplanted because they were either removed from the waiting list (n = 13) or died (n = 10). Intention-to-treat median survival was superior in the LR group compared with the LT-listed group (61.8 months vs. 30.6 months), but the difference did not reach significance. Five-year recurrence was higher in the LR group than in the 52 LT patients (71.5% vs. 30.5%; P < 0.001).
CONCLUSIONS: In the context of limited donor organ availability, partial hepatectomy represents an efficacious primary approach in properly selected patients with hepatitis C-associated HCC.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 23036070      PMCID: PMC3719920          DOI: 10.1111/j.1477-2574.2012.00548.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  36 in total

1.  No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data.

Authors:  Y Futagawa; P I Terasaki; K Waki; J Cai; D W Gjertson
Journal:  Am J Transplant       Date:  2006-06       Impact factor: 8.086

2.  The natural history of hepatitis C cirrhosis after liver transplantation.

Authors:  Roberto J Firpi; Virginia Clark; Consuelo Soldevila-Pico; Giuseppe Morelli; Roniel Cabrera; Cynthia Levy; Victor I Machicao; Chen Chaoru; David R Nelson
Journal:  Liver Transpl       Date:  2009-09       Impact factor: 5.799

3.  Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.

Authors:  Carlos Margarit; Alfredo Escartín; Lluis Castells; Víctor Vargas; Elena Allende; Itxarone Bilbao
Journal:  Liver Transpl       Date:  2005-10       Impact factor: 5.799

4.  The association between hepatitis C infection and survival after orthotopic liver transplantation.

Authors:  Lisa M Forman; James D Lewis; Jesse A Berlin; Harold I Feldman; Michael R Lucey
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

5.  Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis.

Authors:  N Nagasue; T Ono; A Yamanoi; H Kohno; O N El-Assal; H Taniura; M Uchida
Journal:  Br J Surg       Date:  2001-04       Impact factor: 6.939

6.  Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?

Authors:  Angel Moya; Marina Berenguer; Victoria Aguilera; Fernando San Juan; David Nicolás; Miguel Pastor; Rafael López-Andujar; Miguel Rayón; Francisco Orbis; Julio Mora; Manuel De Juan; Domingo Carrasco; Juan-José Vila; Martín Prieto; Joaquín Berenguer; José Mir
Journal:  Liver Transpl       Date:  2002-11       Impact factor: 5.799

7.  Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study.

Authors:  J Figueras; L Ibañez; E Ramos; E Jaurrieta; J Ortiz-de-Urbina; F Pardo; J Mir; C Loinaz; L Herrera; P López-Cillero; J Santoyo
Journal:  Liver Transpl       Date:  2001-10       Impact factor: 5.799

8.  Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

Authors:  J Bruix; A Castells; J Bosch; F Feu; J Fuster; J C Garcia-Pagan; J Visa; C Bru; J Rodés
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

9.  Surgical management of early-stage hepatocellular carcinoma: resection or transplantation?

Authors:  Emily C Bellavance; Kimberly M Lumpkins; Gilles Mentha; Hugo P Marques; Lorenzo Capussotti; Carlo Pulitano; Pietro Majno; Paulo Mira; Laura Rubbia-Brandt; Alessandro Ferrero; Luca Aldrighetti; Steven Cunningham; Nadia Russolillo; Benjamin Philosophe; Eduardo Barroso; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2008-08-15       Impact factor: 3.452

10.  Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience.

Authors:  Qiang Li; Huikai Li; Yu Qin; P Peter Wang; Xishan Hao
Journal:  J Gastroenterol Hepatol       Date:  2007-11       Impact factor: 4.029

View more
  4 in total

1.  Resection or Transplant in Early Hepatocellular Carcinoma.

Authors:  Markus B Schoenberg; Julian N Bucher; Adrian Vater; Alexandr V Bazhin; Jingcheng Hao; Markus O Guba; Martin K Angele; Jens Werner; Markus Rentsch
Journal:  Dtsch Arztebl Int       Date:  2017-08-07       Impact factor: 5.594

Review 2.  Current management of hepatocellular carcinoma.

Authors:  Parissa Tabrizian; Sasan Roayaie; Myron E Schwartz
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

3.  Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients.

Authors:  Jin Hean Koh; Darren Jun Hao Tan; Yuki Ong; Wen Hui Lim; Cheng Han Ng; Phoebe Wen Lin Tay; Jie Ning Yong; Mark D Muthiah; Eunice X Tan; Ning Qi Pang; Beom Kyung Kim; Nicholas Syn; Alfred Kow; Brian K P Goh; Daniel Q Huang
Journal:  Hepatobiliary Surg Nutr       Date:  2022-02       Impact factor: 8.265

4.  Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities.

Authors:  Pegah Golabi; Sofie Fazel; Munkhzul Otgonsuren; Mehmet Sayiner; Cameron T Locklear; Zobair M Younossi
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.